Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CYLD-mediated lysine63 deubiquitination regulates synaptic transmission and autophagy to mitigate age-related sequelae.

Nature communications·2026

Same author

The nuclear shredder behind PARPi resistance.

Nature cell biology·2026

Same author

Niemann Pick Type C Presenting as Familial Late-Onset Richardson Syndrome. A Case Series of Four Siblings.

Movement disorders clinical practice·2026

Same author

Specific genes of the dopaminergic (dop-3) and serotonergic (tph-1) pathways contribute to the effects of ethanol consumption in Caenorhabditis elegans.

PloS one·2026

Same author

ALKB-1-dependent tRNA methylation is required for efficient paternal mitochondrial elimination.

Nature communications·2026

Same author

The Mitochondrial Guardian α-Amyrin Mitigates Alzheimer's Disease Pathology via Modulation of the DLK-SARM1-ULK1 Axis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same journal

Anterior Cingulate Cortex Mediates State-Dependent Prioritization of Distressed Conspecifics.

Brain sciences·2026

Same journal

Hemispherotomy for Pediatric Post-Traumatic Epilepsy.

Brain sciences·2026

Same journal

When Robots Learn: Artificial Intelligence and the Next Human-Centered Era of Neurorehabilitation.

Brain sciences·2026

Same journal

The Association Between Changes in White Matter Microstructure and Cognitive Function in Older Adults with Mild Cognitive Impairment.

Brain sciences·2026

Same journal

Beyond Ventricular Enlargement: Multimodal MRI Assessment Improves Surgical Decision-Making in Normal Pressure Hydrocephalus.

Brain sciences·2026

Same journal

The Effects of Personalized Observation, Execution, and Mental Imagery (POEM) Therapy in Logopenic Primary Progressive Aphasia: A Telepractice-Based Single-Case Study.

Brain sciences·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 21, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Molecular Interventions towards Multiple Sclerosis Treatment.

Athanasios Metaxakis¹, Dionysia Petratou¹, Nektarios Tavernarakis^1,2

¹Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas, Nikolaou Plastira 100, 70013 Heraklion, Crete, Greece.

|May 21, 2020

Summary

This summary is machine-generated.

Multiple sclerosis (MS) treatments are advancing with immunotherapies like peptide vaccination and monoclonal antibodies. These therapies aim to rebalance the immune response, offering promising avenues for managing this autoimmune disease.

Keywords:

B cell receptor T cell receptor delivery methods immunotherapy monoclonal antibodies multiple sclerosis tolerance vaccine

More Related Videos

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Related Experiment Videos

Last Updated: Dec 21, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Area of Science:

Neuroimmunology
Autoimmune Diseases

Background:

Multiple sclerosis (MS) is a chronic autoimmune disorder affecting millions globally.
Current MS treatments, while advancing, offer only partial disease inhibition in humans.
Animal models like experimental autoimmune encephalomyelitis (EAE) are crucial for studying MS.

Purpose of the Study:

To review molecular immunotherapeutic approaches for multiple sclerosis (MS).
To highlight strategies for modulating immune responses in MS.
To assess the potential of novel therapies for MS treatment.

Main Methods:

Review of immunotherapeutic strategies including peptide vaccination, monoclonal antibodies, and immunogenic copolymers.
Analysis of mechanisms targeting T helper 2 cell responses, cytotoxic T cells, and cytokine secretion.
Evaluation of therapeutic efficacy in animal models (EAE) and human clinical trials.

Main Results:

Immunotherapies can effectively treat EAE in animal models.
These approaches partially inhibit disease progression in human MS patients.
Therapeutic strategies aim to reduce autoimmune responses and lymphocyte infiltration in the CNS.

Conclusions:

Modern immunotherapies represent the most promising strategy for developing safe MS treatments.
Targeting cellular factors initiating MS is key to effective therapeutic development.
Continued research in molecular immunotherapy holds significant potential for MS management.